Back to Archived Journals » Comparative Effectiveness Research » Volume 7
Original Research
Cost-effectiveness of sunitinib as second-line treatment for gastrointestinal stromal tumor in the People’s Republic of China
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,075 | Dovepress* | 11,075+ | 818 | 11,893 | |
Totals | 11,075 | 818 | 11,893 | ||
*Since 23 January 2017 |
View citations on Google Scholar